Medical advances including cancer therapies and surgical innovations will be explored in a new season of the podcast Tomorrow’s Cure.
Produced by Mayo Clinic, the chart-topping podcast returns for its fifth season on 24 June, introducing journalist Lindsey Seavert as its new host.
Lindsey, an Emmy and Edward R. Murrow Award winning journalist, will lead discussions with researchers, physicians and industry experts about developments that could shape future healthcare.
The new season will feature conversations with experts working across cancer treatment, surgery and emerging therapies.
The opening episode explores carbon ion therapy, a new form of heavy particle radiation treatment being developed for some of the most difficult and treatment resistant cancers.
Host Lindsey Seavert speaks to Mayo Clinic radiation oncologist Dr Adam Holtzman and Dr Paige Taylor from UT MD Anderson Cancer Center about how the treatment works, why it may offer greater precision than conventional radiation, and what it could mean for patients with tumours that are difficult to remove or have not responded to existing therapies.
Discussing the technology, Dr Holtzman says carbon ion therapy could help cancers that are resistant to existing treatments because it may “pack a little bit more punch” while still protecting healthy tissue.
Looking ahead, he adds: “I really think of it as the first step in personalised radiation oncology.”
The episode also examines Mayo Clinic’s new carbon ion therapy centre in Florida, which is expected to begin treating patients in 2028.
Dr Taylor describes the development as “a really exciting advancement” that will give doctors “another tool in our toolbox for some of these really hard to treat tumours”, while both guests explain the years of research, engineering and testing behind bringing the technology to the United States for the first time.
The series also includes an interview with Timothy Lautz. He explains how fluorescence guided surgery is helping surgeons visualise tumours, nerves and blood flow during procedures, with the aim of making operations safer, more accurate and less invasive.
Another episode features Melinda Bachini from the Cholangiocarcinoma Foundation. She discusses cholangiocarcinoma, a rare bile duct cancer, and examines how research into RNA therapeutics and targeted drug delivery could influence future treatment options.
The podcast is aimed at patients, healthcare professionals and listeners interested in medical innovation, highlighting research and technologies that are already beginning to change healthcare.
Season five of Tomorrow’s Cure will release weekly episodes on all podcast platforms with the first episode available now.
